Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
Sign Up to like & getrecommendations! Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4289-0
Abstract: Aims/hypothesisSemaglutide is a glucagon-like peptide-1 analogue in development for the treatment of type 2 diabetes. Its effects on first- and second-phase insulin secretion and other measures of beta cell function and glycaemic control were assessed.MethodsIn… read more here.
Keywords: function glycaemic; treatment; cell function; glycaemic control ... See more keywords
Impact of insulin sensitivity, beta‐cell function and glycaemic control on initiation of second‐line glucose‐lowering treatment in newly diagnosed type 2 diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes"
DOI: 10.1111/dom.12894
Abstract: The aim of this study was to investigate whether insulin sensitivity, beta‐cell function or glycaemic control at diagnosis predict initiation of second‐line treatment in newly diagnosed type 2 diabetes. read more here.
Keywords: function glycaemic; cell function; sensitivity beta; glycaemic control ... See more keywords